---
layout: page
title: Publications
permalink: /publications/
toggle: on
rank: 4
---
\*Authors contributed equally<br>

Members of the Morin laboratory indicated in **boldface**

## 2018

**A Novel Multiplex droplet digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical Specimens.**<br>
**Alcaide M**, **Cheung M**, **Bushell K**, **Arthur S**,  **Wong HL**, Karasinska J, Renouf D,  Schaeffer DF, McNamara S, Couetoux du Tertre M, Batist G, Kennecke HF, Karsan K and **Morin RD**.<br>
Journal of Molecular Diagnostics (In Press)

[**Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma.**](https://www.ncbi.nlm.nih.gov/pubmed/30275490)
<br>
**Arthur SE**\*, **Jiang A**\*, **Grande BM**\*, **Alcaide M**, Cojocaru R, **Rushton CK**, Mottok A, **Hilton LK**, Lat PK, Zhao EY, Culibrk L, Ennishi D, **Jessa S**, **Chong L**, **Thomas N**, **Pararajalingam P**, Meissner B, Boyle M, **Davidson J**, **Bushell KR**, Lai D, Farinha P, Slack GW, Morin GB, Shah S, Sen D, Jones SJM, Mungall AJ, Gascoyne RD, Audas TE, Unrau P, Marra MA, Connors JM, Steidl C, Scott DW, **Morin RD**.
<br>
Nat Commun. 2018 Oct 1;9(1):4001. doi: 10.1038/s41467-018-06354-3.

[**Novel Multiplexing Strategies for Quantification of Rare Alleles Using ddPCR.**](https://www.ncbi.nlm.nih.gov/pubmed/29717449)
<br>
**Alcaide M**, **Morin RD**.
<br>
Methods Mol Biol. 2018;1768:275-301. doi: 10.1007/978-1-4939-7778-9\_16.

[**The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples.**](https://www.ncbi.nlm.nih.gov/pubmed/29295643)
<br>
Wever CM, Geoffrion D, **Grande BM**, **Yu S**, **Alcaide M**, Lemaire M, Riazalhosseini Y, HÃ©bert J, Gavino C, Vinh DC, Petrogiannis-Haliotis T, Dmitrienko S, Mann KK, **Morin RD**\*, Johnson NA\*.
<br>
Leuk Lymphoma. 2018 Sep;59(9):2159-2174. doi: 10.1080/10428194.2017.1413186. 


## 2017

[**Targeted Error-Suppressed Detection of Circulating Paternal DNA to Establish a Diagnosis of Gestational Trophoblastic Neoplasm**](http://ascopubs.org/doi/abs/10.1200/PO.17.00154)<br>
Jean-Michel Lavoie, **Miguel Alcaide**, Rosemary A. Fisher, Michael J. Seckl, **Ryan Morin**, and Anna V. Tinker<br>
JCO Precision Oncology 2017 :1, 1-6 

[**Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits.**](https://www.ncbi.nlm.nih.gov/pubmed/28874686)
<br>
**Alcaide M**, **Yu S**, **Davidson J**, **Albuquerque M**, **Bushell K**, **Fornika D**, **Arthur S**, **Grande BM**, McNamara S, Tertre MCD, Batist G, Huntsman DG, Cavallone L, Aguilar A, Basik M, Johnson NA, Deyell RJ, Rassekh SR, **Morin RD**.
<br>
Sci Rep. 2017 Sep 5;7(1):10574. doi: 10.1038/s41598-017-10269-2.

[**Investigating the Genetic Causes of Sudden Unexpected Death in Children Through Targeted Next-Generation Sequencing Analysis.**](https://www.ncbi.nlm.nih.gov/pubmed/28807990)
<br>
Dewar LJ\*, **Alcaide M**\*, **Fornika D**, **D'Amato L**, Shafaatalab S, Stevens CM, Balachandra T, Phillips SM, Sanatani S, **Morin RD**&ast;, Tibbits GF&ast;.
<br>
Circ Cardiovasc Genet. 2017 Aug;10(4). pii: e001738. doi: 10.1161/CIRCGENETICS.116.001738.

[**Kronos: a workflow assembler for genome analytics and informatics.**](https://www.ncbi.nlm.nih.gov/pubmed/28655203)
<br>
Taghiyar MJ, Rosner J, Grewal D, **Grande BM**, Aniba R, **Grewal J**, Boutros PC, **Morin RD**, Bashashati A, Shah SP.
<br>
Gigascience. 2017 Jul 1;6(7):1-10. doi: 10.1093/gigascience/gix042.

[**Enhancing knowledge discovery from cancer genomics data with Galaxy.**](https://www.ncbi.nlm.nih.gov/pubmed/28327945)
<br>
**Albuquerque MA**, **Grande BM**, **Ritch EJ**, **Pararajalingam P**, **Jessa S**, Krzywinski M, **Grewal JK**, Shah SP, Boutros PC, **Morin RD**.
<br>
Gigascience. 2017 May 1;6(5):1-13. doi: 10.1093/gigascience/gix015.


## 2016

[**Multiplex Droplet Digital PCR Quantification of Recurrent Somatic Mutations in Diffuse Large B-Cell and Follicular Lymphoma.**](https://www.ncbi.nlm.nih.gov/pubmed/27440511)
<br>
**Alcaide M**, **Yu S**, **Bushell K**, **Fornika D**, Nielsen JS, Nelson BH, Mann KK, Assouline S, Johnson NA, **Morin RD**.
<br>
Clin Chem. 2016 Sep;62(9):1238-47. doi: 10.1373/clinchem.2016.255315. 

[**Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies.**](https://www.ncbi.nlm.nih.gov/pubmed/27422709)
<br>
Volik S, **Alcaide M**, **Morin RD**, Collins C.
<br>
Mol Cancer Res. 2016 Oct;14(10):898-908. 

[**Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma.**](https://www.ncbi.nlm.nih.gov/pubmed/27166360)
<br>
Assouline SE, Nielsen TH, **Yu S**, **Alcaide M**, **Chong L**, MacDonald D, Tosikyan A, Kukreti V, Kezouh A, Petrogiannis-Haliotis T, **Albuquerque M**, **Fornika D**, **Alamouti S**, Froment R, Greenwood CM, Oros KK, Camglioglu E, Sharma A, Christodoulopoulos R, Rousseau C, Johnson N, Crump M, **Morin RD**\*, Mann KK\*.
<br>
Blood. 2016 Jul 14;128(2):185-94. doi: 10.1182/blood-2016-02-699520. 

[**Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.**](https://www.ncbi.nlm.nih.gov/pubmed/26647218)
<br>
**Morin RD**, Assouline S, **Alcaide M**, **Mohajeri A**, **Johnston RL**, **Chong L**, **Grewal J**, **Yu S**, **Fornika D**, **Bushell K**, Nielsen TH, Petrogiannis-Haliotis T, Crump M, Tosikyan A, **Grande BM**, MacDonald D, Rousseau C, Bayat M, Sesques P, Froment R, **Albuquerque M**, Monczak Y, Oros KK, Greenwood C, Riazalhosseini Y, Arseneault M, Camlioglu E, Constantin A, Pan-Hammarstrom Q, Peng R, Mann KK, Johnson NA.
<br>
Clin Cancer Res. 2016 May 1;22(9):2290-300. doi: 10.1158/1078-0432.CCR-15-2123. 


## 2015

[**Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.**](https://www.ncbi.nlm.nih.gov/pubmed/25468570)
<br>
**Bushell KR**, **Kim Y**, Chan FC, Ben-Neriah S, **Jenks A**, **Alcaide M**, **Fornika D**, **Grande BM**, **Arthur S**, Gascoyne RD, Steidl C, **Morin RD**.
<br>
Blood. 2015 Feb 5;125(6):999-1005. doi: 10.1182/blood-2014-10-602714. 
